Acamprosate
- Generic Name
- Acamprosate
- Brand Names
- Campral
- Drug Type
- Small Molecule
- Chemical Formula
- C5H11NO4S
- CAS Number
- 77337-76-9
- Unique Ingredient Identifier
- N4K14YGM3J
- Background
Alcohol use disorder is responsible for a large worldwide burden of morbidity, premature mortality, and economic consequences resulting from accidents, violence, incarceration, decreased productivity, and increased healthcare spending.
...
- Indication
Acamprosate is indicated for the maintenance of abstinence from alcohol in patients with alcohol dependence who are abstinent at treatment initiation. It is also indicated for the maintenance of alcohol abstinence in patients who have undergone alcohol detoxification. This drug should be used with a psychosocial support program providing adequate support.
- Associated Conditions
- Alcohol Abstinence, Alcohol Dependency
- Associated Therapies
- -
Acamprosate in the Treatment of Binge-Eating Disorder
- First Posted Date
- 2007-08-06
- Last Posted Date
- 2011-06-22
- Lead Sponsor
- Lindner Center of HOPE
- Target Recruit Count
- 40
- Registration Number
- NCT00511940
- Locations
- 🇺🇸
Lindner Center of HOPE, Mason, Ohio, United States
Acamprosate vs. Placebo in Bipolar Alcoholics
- Conditions
- Interventions
- First Posted Date
- 2007-04-27
- Last Posted Date
- 2018-12-14
- Lead Sponsor
- Medical University of South Carolina
- Target Recruit Count
- 33
- Registration Number
- NCT00466661
- Locations
- 🇺🇸
Institute of Psychiatry, Medical University of South Carolina, Charleston, South Carolina, United States
Treatment With Acamprosate in Patients With Schizophrenia and Comorbid Alcoholism
- Conditions
- Interventions
- First Posted Date
- 2007-04-20
- Last Posted Date
- 2020-03-31
- Lead Sponsor
- Yale University
- Target Recruit Count
- 23
- Registration Number
- NCT00463346
- Locations
- 🇺🇸
VA Connecticut Healthcare System, West Haven, Connecticut, United States
Acamprosate Added to Escitalopram and Behavioral Treatment for Comorbid Depression and Alcoholism
- Conditions
- Interventions
- First Posted Date
- 2007-03-27
- Last Posted Date
- 2012-07-09
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 23
- Registration Number
- NCT00452543
- Locations
- 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
Comparative Trial Of Disulfiram, Naltrexone And Acamprosate In The Treatment Of Alcohol Dependence
- Conditions
- First Posted Date
- 2007-02-15
- Last Posted Date
- 2007-02-16
- Lead Sponsor
- Finnish Institute for Health and Welfare
- Target Recruit Count
- 243
- Registration Number
- NCT00435435
- Locations
- 🇫🇮
National Public Health Institute, Department of Mental Health and Alcohol Research, Helsinki, Finland
Study of Acamprosate in Driving Under the Influence (DUI) Court Participants
- First Posted Date
- 2007-01-23
- Last Posted Date
- 2012-07-27
- Lead Sponsor
- University of Oklahoma
- Target Recruit Count
- 4
- Registration Number
- NCT00425711
- Locations
- 🇺🇸
The University of Oklahoma, Tulsa, Tulsa, Oklahoma, United States
Pilot Trial of Acamprosate for the Treatment of Cocaine Dependence
- First Posted Date
- 2006-10-09
- Last Posted Date
- 2020-07-10
- Lead Sponsor
- University of Pennsylvania
- Target Recruit Count
- 60
- Registration Number
- NCT00385268
- Locations
- 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States
Acamprosate Initiated During Alcohol Detoxification
- First Posted Date
- 2006-08-04
- Last Posted Date
- 2017-01-11
- Lead Sponsor
- Forest Laboratories
- Target Recruit Count
- 40
- Registration Number
- NCT00360594
- Locations
- 🇺🇸
Treatment Research Center, Philadelphia, Pennsylvania, United States
Open Label Trial of Acamprosate in Bipolar Alcoholics
- Conditions
- First Posted Date
- 2006-05-26
- Last Posted Date
- 2008-09-19
- Lead Sponsor
- Medical University of South Carolina
- Target Recruit Count
- 9
- Registration Number
- NCT00330486
- Locations
- 🇺🇸
Institute of Psychiatry, Medical University of South Carolina, Charleston, South Carolina, United States
Acamprosate in Alcoholics With Comorbid Anxiety or Depression
- Conditions
- Interventions
- First Posted Date
- 2006-05-26
- Last Posted Date
- 2015-04-13
- Lead Sponsor
- Medical University of South Carolina
- Target Recruit Count
- 90
- Registration Number
- NCT00330174
- Locations
- 🇺🇸
Columbia University College of Physicians & Surgeons, New York, New York, United States
🇺🇸Behavioral Health Services of Pickens County, Pickens, South Carolina, United States
🇺🇸McLean Hospital, Belmont, Massachusetts, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.